The source of Ca 2؉ to activate pathological cardiac hypertrophy is not clearly defined. Ca 2؉ influx through the L-type Ca 2؉ channels (LTCCs) determines "contractile" Ca 2؉ , which is not thought to be the source of "hypertrophic" Ca 2؉ . However, some LTCCs are housed in caveolin-3 (Cav-3)-enriched signaling microdomains and are not directly involved in contraction. The function of these LTCCs is unknown.
C ardiovascular diseases increase cardiac systolic stress and cause myocyte hypertrophy. Increases in Ca 2ϩ influx during pathological stress maintain pump function and activate signaling pathways that produce pathological hypertrophy and heart failure, 1,2 but the source of this "hypertrophic" Ca 2ϩ still is not clearly defined.
Increases in Ca 2ϩ influx are essential for the activation of pathological hypertrophic signaling, including the calcineurin-nuclear factor of activated T-cells (Cn-NFAT) pathway, 2,3 the calmodulin-dependent protein kinase pathway, 4 and the protein kinase C pathway. 5 The source of the Ca 2ϩ that activates each of these signaling cascades is still not well-known. Potential sources include L-type 6, 7 and T-type 8, 9 Ca 2ϩ channels and transient receptor potential channels. 10 In cardiac myocytes, voltage-dependent L-type Ca 2ϩ channels (LTCC, Cav1.2) are the predominant Ca 2ϩ entry path-way and are essential for excitation-contraction coupling and regulation of gene expression. 1 Myocyte LTCCs are concentrated in T-tubular membranes, where they are organized in junctional complexes with ryanodine receptors on the sarcoplasmic reticulum 1 to form a signaling microdomain involved in Ca 2ϩ -induced sarcoplasmic reticulum Ca 2ϩ release. This microdomain is the source of "contractile" [Ca 2ϩ ].
Not all LTCCs are involved in Ca 2ϩ -induced sarcoplasmic reticulum Ca 2ϩ release. A small fraction appears to be harbored in caveolae, 11 which are highly specialized membrane regions that are stabilized by the scaffolding protein caveolin. Caveolin-3 is the major caveolin expressed in the heart and it functions to help organize local signaling microdomains. 11 The function of caveolae-based LTCCs are unknown and are the topic of this study.
Our studies test the hypothesis that "hypertrophic" Ca 2ϩ enters the myocyte through LTCCs localized in Cav-3-based signaling microdomains and that this "signaling" Ca 2ϩ is distinct from "contractile" Ca 2ϩ . This idea was examined with a novel LTCC blocker that selectively traffics to caveolae, where it inhibits LTCCs within this signaling microdomain. Our results show that this Cav-3-localized LTCC antagonist can block "hypertrophic" Ca 2ϩ without altering contractility. The caveolae targeted LTCC blocker was generated by molecular modification of Rem, a member of the RGK GTPase family that is known to potently inhibit LTCCs. 12 Expressing wild-type Rem in cardiac myocytes blocked L-type Ca 2ϩ channel current (I Ca-L ), and this inhibition required a c-terminal membrane-docking domain. 13 Truncation of this membrane-docking domain (Rem 1-265 ) resulted in the inability of Rem to traffic to the membrane and to inhibit I Ca-L . To specifically block caveolae-based LTCCs, the membrane-binding motif of native Rem was deleted and replaced with a canonical caveolin-targeting domain sequence 14 to create Rem 1-265 -Cav. Rem 1-265 -Cav targeted se- 
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Cav-3 caveolin-3
Cn calcineurin LTCC L-type calcium channel NFAT nuclear factor of activated T cells lectively to Cav-3 membranes and did not alter myocyte contractility, but it blocked Ca 2ϩ -influx-mediated activation of Cn-NFAT signaling. These data strongly support the hypothesis that LTCCs housed in Cav-3-containing microdomains is a source of "hypertrophic" Ca 2ϩ .
Methods
All methods have been described in detail previously. 7, [15] [16] [17] Detailed Methods are provided in the Online Supplement. Adult feline left ventricular myocytes (AFLVMs) were isolated 15 and adenoviral gene transfer was used to introduce wild-type (WT)-Rem, Rem 1-265 , Rem 1-265 -Cav, or NFATc3-GFP, 17 all at a multiplicity of infection of 100. Myocytes were cultured for a period of up to 4 days. Localization of AdRem constructs was confirmed using standard sucrose gradient fractionation and caveolin-3 immunoisolation techniques. 16 
Results
Rem 1-265 -Cav Localizes to Caveolae
Native Rem was not detected in plasma membrane (PM) from AFLVMs. After adenoviral infection, WT-Rem was found in all AFLVM membrane fractions, consistent with the idea that it is in all PM domains. The Rem 1-265 peptide lacking the membrane association motif remained in the general cell homogenate. Rem 1-265 -Cav localized to PM specifically within caveolin-containing lipid rafts ( Figure 1A) , verifying target specificity of the peptide containing the Cav-binding motif. Rem 1-265 -Cav did not alter the normal raft or caveolae targeting of LTCCs, endothelial nitric oxide synthase, and caveolin-3, which demonstrates that Rem 1-265 -Cav does not displace molecules normally found in caveolae ( Figure 1A ). To prove that Rem 1-265 -Cav specifically localizes to caveolae, rather than lipid rafts in general, caveolae organelles were immunoaffinity-purified. 16 Similar to our observation in raft membranes, only Rem 1-265 -Cav was seen in association with caveolin-3 ( Figure 1B) . These data show that Rem 1-265 -Cav specifically traffics to Cav-3 membrane microdomains.
To further assess what fraction of LTCCs localizes to caveolae membrane domains, PM samples were purified from AFLVMs and subjected to immunoaffinity isolation with anti-Cav-3 ( Figure 1C ). The unbound fraction from the Cav-3 immunoprecipitation (IP) was then re-IM for Cav1.2 ( Figure  1C ). Densitometric analysis (nϭ3) showed that 26.2%Ϯ12.7% of LTCCs reside within caveolae. To estimate the fraction of caveolae that contain LTCCs, AFLVM PM preparations were immunoprecipitated with an antibody for Cav1.2 (LTCC). The resulting unbound fraction was then re-IM for Cav-3 and the intensity of the bands in both fractions were compared. Only 13.4%Ϯ10.1% (nϭ3) of caveolae PM contained LTCCs.
Rem 1-265 -Cav Blocks a Small Fraction of I Ca,L and Has No Effect on Contractility
WT-Rem almost fully eliminated the L-type Ca 2ϩ channel current (I Ca,L ) in AFLVMs at an multiplicity of infection of 100 (Figure 2A ). Rem 1-265 had no significant effect on I Ca,L . (Figure 2A ). The smaller I Ca,L block with Rem 1-265 -Cav versus WT-Rem suggests that only a small fraction of LTCCs are localized to Cav-3-signaling microdomains.
Inhibition of I Ca,L with WT-Rem eliminates LTCC regulation by catecholamines. 12 AFLVMs infected with Rem 1-265 -Cav responded normally to isoproterenol (Figure 2A) , whereas those infected with WT-Rem did not respond (not shown). Myocytes infected with WT-Rem had markedly reduced fractional shortening (1.1%Ϯ0.1% resting cell length), whereas those infected with truncated Rem 1-265 (5.0%Ϯ0.5%) and Rem 1-265 -Cav (4.4%Ϯ0.4%) had contractions that were not significantly smaller than those of controls (4.7%Ϯ0.5%; Figure 2B ). [Ca 2ϩ ] i transients were also unaffected by Rem 1-265 -Cav ( Figure 2C) . Collectively, these data support the idea that Rem 1-265 -Cav blocks a small fraction of Cav-3-associated LTCCs without significantly effecting myocyte excitation-contraction coupling.
Rem 1-265 -Cav Inhibits the ␤ 2 -Adrenergic Regulation of LTCCs
Myocyte Cav-3 membrane domains are thought to contain both LTCCs and ␤ 2 -adrenergic receptors. 11 The ␤ 2adrenergic receptor-specific agonist Zinterol in the presence of the ␤ 1 -adrenergic receptor-specific antagonist CGP 20712 A increased I Ca,L and fractional shortening in AFLVMs. This effect was inhibited by Rem 1-265 -Cav (Figure 3 ), suggesting that Rem 1-265 -Cav can selectively block Ca 2ϩ entry through ␤ 2 -adrenergic receptor-regulated LTCCs within Cav-3-signaling microdomains.
Rem 1-265 -Cav Inhibits NFAT Translocation to the Nucleus
AFLVMs infected with AdNFATc3-GFP or AdNFATc3-GFP and AdRem 1-265 -Cav were electrically quiescent in culture. AFLVMs maintain low levels of cytosolic [Ca 2ϩ ] with little or no spontaneous sarcoplasmic reticulum Ca 2ϩ release 9 and NFATc3-GFP is localized to the cytoplasm. 17 NFAT localization (cytoplasmic vs nuclear) was measured before (Figure 4A , C) and after ( Figure 4B, D) 1-Hz pacing for 1 hour. Pacing caused NFAT to translocate from the cytoplasm to the nucleus in control AFLVMs ( Figure 4B ). AFLVMs infected with Rem 1-265 -Cav had normal contractions and Ca 2ϩ transients (shown), but more than 90% of NFAT nuclear translocation was inhibited ( Figure 4E, F) . These results were confirmed in experiments in which bath Ca 2ϩ was increased to 4 mmol/L, which also induced NFAT to translocate to the nucleus in control cells. Rem 1-265 -Cav inhibited NFAT translocation under these conditions (data not shown).
Discussion
Ca 2ϩ -calmodulin-dependent activation of Cn-NFAT 2,3 produces pathological hypertrophy. Activation of this signaling cascade requires an increase in myocyte [Ca 2ϩ ]. "Contractile" [Ca 2ϩ ] does not appear to activate this hypertrophic process. 6 The sources of "hypertrophic" [Ca 2ϩ ] to activate Cn-NFAT signaling are not clearly defined. There is some evidence for a role for the LTCC; 6,7 however, there is also evidence for Ca 2ϩ entry through T-type Ca 2ϩ channels 8, 9 and transient receptor potential channels. 10 The role of T-type Ca 2ϩ channels is controversial because some studies suggest that this pathway is antihypertrophic 8 rather than prohypertrophic. 9 The observation that excess Ca 2ϩ influx through T-type Ca 2ϩ channels is antihypertrophic 8 suggests that Ca 2ϩ influx per se is not prohypertrophic or antihypertrophic. Rather, the pathway for Ca 2ϩ influx and possibly the localization of this pathway appear to be critical.
The present experiments suggest that a small number of LTCCs are localized in a fraction of Cav-3-containing membranes to form a signaling microdomain that can activate Cn-NFAT signaling. Our results are consistent with a recent study suggesting that a subpopulation of LTCCs in Cav-3containing membranes are housed with AKAP150, which binds Cn. 18 These Cav-3-localized LTCCs do not participate in excitation-contractoin coupling or the regulation of "contractile" Ca 2ϩ . Our Cav-3-targeting strategy was able to selectively traffic an LTCC-blocking Rem protein (Rem 1-265 -Cav) to this signaling domain to block hypertrophic signaling without significantly reducing contraction or ␤1AR regulation of contractility. Our results suggest that any LTCCs associated with the small amount of Cav-3 that others have found within T-tubules do not participate in excitationcontraction coupling. 19 Our results also show that not all Cav-3-containing membrane domains contain LTCCs, suggesting that hypertrophic signaling may take place in highly specialized signaling complexes. The signaling partners within these domains and their regulation in health and disease needs to be determined in future studies.
LTCCs are the major Ca 2ϩ influx pathway in the adult mammalian heart, and these channels are regulated biosensors that determine myocyte contractility and cardiac pump function. 1 Our results suggest that nature uses a subpopulation of these channels, housed away from excitation-contraction coupling signaling domains, as a source of Ca 2ϩ to modulate myocyte size when the heart is subjected to stress. Selective block of this Ca 2ϩ influx pathway by the novel reagents developed in this study might provide an approach to reduce pathological hypertrophy without reducing cardiac contractility. 
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